Virax Biolabs (VRAX) Cash & Equivalents (2021 - 2026)
Virax Biolabs (VRAX) recorded Cash & Equivalents of $6.44 million in fiscal Q4 2026 (quarter ended Mar 31, 2026), up 52.3% from $4.23 million a year earlier.
Powered by 
Analysis
Virax Biolabs (VRAX) Cash & Equivalents (2021 - 2026) Analysis & Trends
Starting with fiscal Q4 2021, Virax Biolabs' Cash & Equivalents history includes 10 quarters.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 225.5% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $4.23 million in FY2025 (-54.8%), $9.35 million in FY2024 (unchanged), $9.35 million in FY2023 and $21,756 in FY2022 (+23.5%).
- The fiscal Q4 2026 figure is the highest quarterly Cash & Equivalents since fiscal Q2 2025.
- On a year-over-year basis, Cash & Equivalents rose in three of the last four quarters, with growth averaging 14.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Virax Biolabs | 862,770.33 | -20.68 Mn | - | 6.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.44 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Sep 30, 2024 | 7.29 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Mar 31, 2023 | 9.35 Mn |
| Sep 30, 2022 | 4.57 Mn |
| Mar 31, 2022 | 21,756.00 |
| Mar 31, 2021 | 17,621.00 |
API Access
Virax Biolabs Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();